Skip to main content

previous disabled Page of 21
and
  1. Article

    Open Access

    Integrated proteomic and metabolomic profiling of lymph after trauma-induced hypercoagulopathy and antithrombotic therapy

    Routine coagulation tests are not widely accepted diagnostic criteria of trauma-induced hypercoagulopathy (TIH) due to insensitivity. Lymphatic vessels drain approximately 10% of the interstitial fluid into th...

    Yangkang Zheng, Pengyu Wang, Lin Cong, Qi Shi, Yongjian Zhao in Thrombosis Journal (2024)

  2. No Access

    Article

    Allogeneic haematopoietic stem cell transplantation might overcome the poor prognosis of adolescents and adult patients with T-lineage acute lymphoblastic leukaemia and CDKN2 deletion

    This study delves into the clinical implications of cyclin-dependent kinase inhibitor 2 (CDKN2) deletion in adult T-lineage acute lymphoblastic leukemia (T-ALL). Among 241 patients included in this study, 57 h...

    **aoshan Hu, Zhixiang Wang, Yuting Qin, Jun Xu, Na Xu in Bone Marrow Transplantation (2024)

  3. No Access

    Article

    Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis

    Bruton’s tyrosine kinase inhibitors (BTKi) exhibit superior efficacy in relapsed/refractory primary central nervous system lymphoma (PCNSL), but few studies have evaluated patients with newly diagnosed PCNSL, ...

    Si-Jun Bai, Jian-**a He, Yuan-Jun Zheng, Ye Geng, Yi-Nan Gao in Annals of Hematology (2024)

  4. Article

    Open Access

    Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation

    Autologous stem cell transplantation (autoHCT) is considered standard of care for newly diagnosed multiple myeloma (MM). Although most patients eventually progress after autoHCT, a small proportion achieve a d...

    Oren Pasvolsky, Zhongya Wang, Denái R. Milton, Mark R. Tanner in Blood Cancer Journal (2024)

  5. No Access

    Article

    A case of acute lung injury in a peripheral blood stem cell donor mobilized with pegylated recombinant human granulocyte colony-stimulating factor

    Pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) has been introduced for the mobilization of peripheral blood stem cells (PBSCs). However, no cases of acute lung injury (ALI) in ...

    Lin Liu, Ding-song Zhang, Xue-juan Zhang in International Journal of Hematology (2024)

  6. Article

    Open Access

    Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway

    Acute myeloid leukemia (AML) is a refractory hematologic malignancy that poses a serious threat to human health. Exploring alternative therapeutic strategies capable of inducing alternative modes of cell death...

    Hong Zheng, Ting Wu, Zhi Lin, Dan Wang in Journal of Cancer Research and Clinical On… (2024)

  7. No Access

    Article

    Immunoty** of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma

    This study aimed to explore the distribution, characteristics and prognostic value of baseline peripheral blood lymphocyte subsets in patients with extranodal NK/T-cell lymphoma (NKTCL). We conducted this cros...

    Fei Qi, Yuce Wei, Meng Wu, Yan Sun, Yan **e, Ning**g Lin in Annals of Hematology (2024)

  8. Article

    Open Access

    Dynamic change in the peritoneal cancer index based on CT after chemotherapy in the overall survival prediction of gastric cancer patients with peritoneal metastasis

    The purpose of this research was to investigate the efficacy of the CT-based peritoneal cancer index (PCI) to predict the overall survival of patients with peritoneal metastasis in gastric cancer (GCPM) after ...

    Yi-Yuan Wei, Jie-Yuan Cai, Lin-Lin Wang in Journal of Cancer Research and Clinical On… (2024)

  9. Article

    Open Access

    Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes

    The synergistic effects of combining arsenic compounds with imatinib against chronic myeloid leukemia (CML) have been established using in vitro data. We conducted a clinical trial to compare the efficacy of t...

    Jie Tian, Yong-** Song, Gao-Chong Zhang in Journal of Cancer Research and Clinical On… (2024)

  10. No Access

    Article

    Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma

    Lin-Rui Gao, **n Li, **nyue Wang, Yuanzheng Liang, Yunpeng Wu, **ao-Li Feng in Leukemia (2024)

  11. No Access

    Article

    Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma

    Natural killer/T-cell lymphoma (NKTCL) is a highly heterogeneous disease with a poor prognosis. However, the genomic characteristics and proper treatment strategies for non-upper aerodigestive tract NKTCL (NUA...

    Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian **ao, Liqun Zou in Leukemia (2024)

  12. No Access

    Article

    Znf687 recruits Brd4-Smrt complex to regulate gfi1aa during neutrophil development

    Neutrophils are key component of the innate immune system in vertebrates. Diverse transcription factors and cofactors act in a well-coordinated manner to ensure proper neutrophil development. Dysregulation of ...

    Lin Yan, Shuiyi Tan, Haihong Wang, Hao Yuan, **aohui Liu, Yi Chen in Leukemia (2024)

  13. Article

    Open Access

    Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway

    The aim of this study was to investigate the anti-tumor effect of resveratrol (RSV) on glioblastoma (GBM) and its specific mechanism in improving the inflammatory response of the tumor microenvironment. The tu...

    Chao Zhang, Qian Peng, Yuhang Tang in Journal of Cancer Research and Clinical On… (2024)

  14. No Access

    Article

    Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia

    Minimal residual disease (MRD) based risk stratification criteria for specific genetic subtypes remained unclear in childhood acute lymphoblastic leukemia (ALL). Among 723 children with newly diagnosed ALL tre...

    **ao-Tong Huang, Chan-Juan Wang, Chao Gao, Tian-Lin Xue in Annals of Hematology (2024)

  15. Article

    Open Access

    Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation

    Multiple myeloma (MM) stands as the second most prevalent hematological malignancy, constituting approximately 10% of all hematological malignancies. Current guidelines recommend upfront autologous stem cell t...

    Te-Lin Hsu, Chun-Kuang Tsai, Chun-Yu Liu, Chiu-Mei Yeh, Fen-Lan Lin in Annals of Hematology (2024)

  16. Article

    Open Access

    An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients

    To develop a model that can assist in the diagnosis and prediction of prognosis for head and neck squamous cell carcinoma (HNSCC).

    Bangjie Chen, Yanxun Han, Shuyan Sheng in Journal of Cancer Research and Clinical On… (2024)

  17. Article

    Open Access

    METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation

    While liver cancer stem cells (CSCs) play a crucial role in hepatocellular carcinoma (HCC) initiation, progression, recurrence, and treatment resistance, the mechanism underlying liver CSC self-renewal remains...

    Meilin Xue, Lei Dong, Honghai Zhang, Yangchan Li in Journal of Hematology & Oncology (2024)

  18. Article

    Open Access

    Develo** a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy

    The study aims to develop and validate a combined model for predicting 3-year cancer-specific survival (CSS) in lung cancer patients treated with stereotactic body radiation therapy (SBRT) by integrating clini...

    Bao-Tian Huang, Ying Wang, Pei-**an Lin in Journal of Cancer Research and Clinical Oncology (2024)

  19. Article

    Open Access

    ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway

    Hepatocellular carcinoma (HCC) is one of the most common malignancies with a high lethality rate. ZMIZ2 is a transcriptional co-activator implicated in various human diseases. However, the role and molecular m...

    Yang Ding, Yumei Ning, Hui Kang, Yuan Yuan, Kun Lin in Experimental Hematology & Oncology (2024)

  20. Article

    Open Access

    Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials

    The numerous first-line treatment regimens for human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer (ABC) necessitate a comprehensive evaluation to inform clinical decision-making. W...

    Junxiao Wang, Yushuai Yu, Qisheng Lin in Journal of Cancer Research and Clinical On… (2024)

previous disabled Page of 21